These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12064305)

  • 1. Science, money, and industry: is commerce corrupting AIDS research?
    Mirken B
    BETA; 2002; 15(2):40-4. PubMed ID: 12064305
    [No Abstract]   [Full Text] [Related]  

  • 2. The African Comprehensive HIV/AIDS Partnerships--a new role for multinational corporations in global health policy.
    Distlerath LM; Macdonald G
    Yale J Health Policy Law Ethics; 2004; 4(1):147-55. PubMed ID: 15052865
    [No Abstract]   [Full Text] [Related]  

  • 3. When times get tough.
    Jong S
    Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
    [No Abstract]   [Full Text] [Related]  

  • 4. Bristol-Myers Squibb launches $2 million AIDS grant program.
    AIDS Read; 2000 Apr; 10(4):208. PubMed ID: 10808603
    [No Abstract]   [Full Text] [Related]  

  • 5. No money, no meds.
    Mabry M
    Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS activists fail to block 'reasonable pricing' reform.
    Gavaghan H
    Nature; 1995 Jan; 373(6512):272. PubMed ID: 7830751
    [No Abstract]   [Full Text] [Related]  

  • 7. Private money for AIDS research.
    Palca J
    Nature; 1986 Aug 28-Sep 3; 322(6082):763. PubMed ID: 3748159
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of clinical research sponsored by pharmaceutical companies: a proposal.
    Sotelo J
    PLoS Med; 2006 Jul; 3(7):e306. PubMed ID: 16805651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UNAIDS and BMS to combat AIDS.
    van der Linde I
    S Afr Med J; 1999 Jun; 89(6):585. PubMed ID: 10443202
    [No Abstract]   [Full Text] [Related]  

  • 10. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy for AIDS: affordable and accessible.
    Kalantri SP
    Natl Med J India; 2004; 17(3):179. PubMed ID: 15253413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical research--money or life?].
    Fretheim A; Sørbye IK
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2908-9. PubMed ID: 14600724
    [No Abstract]   [Full Text] [Related]  

  • 13. We can change the way we develop and fund drugs.
    Radcliffe M
    Nurs Times; 2009 Jun; 105(23):32. PubMed ID: 19624056
    [No Abstract]   [Full Text] [Related]  

  • 14. DPI delivers biotechnology superstore. Discovery Partners International.
    Glaser V
    Nat Biotechnol; 1998 Dec; 16(13):1302. PubMed ID: 9853596
    [No Abstract]   [Full Text] [Related]  

  • 15. Funding alert: wake up and support WORLD.
    James JS
    AIDS Treat News; 2003 May; (391):6-7. PubMed ID: 12866498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco money at the University of California.
    Glantz SA
    Am J Respir Crit Care Med; 2005 May; 171(10):1067-9. PubMed ID: 15879426
    [No Abstract]   [Full Text] [Related]  

  • 17. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 18. AAFP-Coke editorial was "music to [our] ears".
    Bieler B
    J Fam Pract; 2010 Feb; 59(2):73-4. PubMed ID: 20391629
    [No Abstract]   [Full Text] [Related]  

  • 19. Millennium mergers bring pipeline.
    Dove A
    Nat Biotechnol; 1999 Dec; 17(12):1151. PubMed ID: 10585700
    [No Abstract]   [Full Text] [Related]  

  • 20. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.